Supplementary Materials

The PDF file includes:

  • Materials and Methods
  • Fig. S1. Redistribution of corepressors by RhCMV pp71.
  • Fig. S2. Description and characterization of pp71-deleted RhCMV vectors.
  • Fig. S3. Summary of recombinant RhCMV/SIV vectors used in vivo.
  • Fig. S4. Tissue distribution of SIV insert–specific CD4+ and CD8+ T cell responses elicited by ΔRh110 versus 68-1 vectors.
  • Fig. S5. Urine shedding of ΔRh110 versus 68-1 vectors.
  • Fig. S6. T cell responses in lung airspace (BAL cells) upon super-infection with pp71-deleted RhCMV vectors.
  • Fig. S7. Boosting of RhCMV Ab responses by ΔRh110 (Δpp71) RhCMV vectors.
  • Fig. S8. Description and characterization of dual insert–expressing, pp71-deleted RhCMV vectors.
  • Fig. S9. CD4+ T cell responses to dual antigen insert–expressing, pp71-deleted RhCMV vectors.
  • Fig. S10. Lack of maternal-infant transmission of pp71-deleted vectors.
  • Fig. S11. Description and characterization of Rh59 (UL35)–deleted RhCMV used in this study.
  • Fig. S12. SIV antigen–specific CD4+ and CD8+ T cell responses elicited by ΔRh59 versus 68-1 RhCMV vectors in tissue sites.
  • Fig. S13. T cell responses to SIV antigens expressed by ΔRh110 and ΔRh59 vectors.
  • References (7681)

[Download PDF]

Other Supplementary Material for this manuscript includes the following: